Antibody-drug conjugates

TW202641599APending Publication Date: 2026-10-16ASTRAZENECA AB
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115107585
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-03-04
Filing Date
2026-03-03
Publication Date
2026-10-16

Smart Images

  • Figure TWG2TA001081167_001
    Figure TWG2TA001081167_001
  • Figure TWG2TA001081167_002
    Figure TWG2TA001081167_002
  • Figure TWG2TA001081167_003
    Figure TWG2TA001081167_003
Patent Text Reader

Abstract

The present invention relates to anti-CD30 antibody-drug conjugates and uses thereof. In particular, the present invention relates to conjugates comprising an anti-CD30 antibody or antigen binding fragment thereof where the conjugate is a dual payload conjugate, i.e. comprising at least two different cytotoxic payloads.
Need to check novelty before this filing date? Find Prior Art